View on market: Stay Cautious, be with quality business:

Asian stocks climbed after U.S. benchmarks halted a three-day slide, with investors migrating to value from growth companies as signs of a strengthening labour market tempered inflation worries. Indices in South Korea, Australia and Japan also gained for the first time in four sessions. The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, rose 1.2% to 14,683.

U.S. futures edged higher, following gains in the major benchmarks. Industrial and financial shares outperformed overnight, while energy producers joined a slump in oil. Bitcoin pared some of the losses sparked by Musk’s comments, trading around $50,000 Treasuries rallied from the prior session’s weakness, with the 10-year yield easing to 1.66% despite a lacklustre auction of 30-year bonds. The Federal Reserve tweaked its purchasing plan to focus more on longer-dated Treasuries, while leaving the $80 billion monthly total unchanged. Meanwhile, concerns about a possible pullback in Fed support have stalled the rally in commodities. Oil slumped the most in over a month as growing inflation concerns raise the spectre of a less accommodative central bank.

Key Data/ Action, Result,IPO and Board meeting to watch

Major economic Data:

  • INR: WPI Inflation (YoY) (Apr) on 14th May, 2021
  • INR: Trade Balance (Apr) on 14th May, 2021
  • USD: Trade Balance (Apr) on 14th May, 2021
  • USD: Industrial Production (YoY) (Apr) on 14th May, 2021

Nifty Results: Larsen & Toubro, Cipla, Dr Reddy’s Laboratories

International Markets:

U.S & Europe

Particulars    13th May. Chg Chg(%)
Nasdaq 13,124.99 93.31 0.72
Dow 34012.45 433.79 1.29
FTSE 6,963.33 -41.3 -0.59
CAC 6,288.33 8.98 0.14
DAX 15,199.68 49.46 0.33
Dow Fut.* 33,999.00 61 0.18

Asian markets:

Particulars    14th May. Chg Chg(%)
SGX Nifty 14,678.00 170.5 1.18
Nikkei 27,940.90 492.89 1.8
Straits Times 3,108.01 -15.25 -0.49
Hang Seng 27,857.25 138.58 0.5
Shanghai 3,447.86 18.32 0.53

ADR Watch:

Particulars       13th May. Chg Chg(%)
Dr Reddy 72.54 1.07 1.50
HDFC Bank 69.51 1.06 1.55
ICICI Bank 16.16 0.24 1.51
Infosys 17.88 0.04 0.22
Tata Motor 21.66 0.26 1.21
Wipro 7.35 0.06 0.82

Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 73.42 0.11
Brent 66.80 -0.37
Gold 1821.65 -0.13
Silver 27.065 0.02


Particulars   12th May. 11th May.
FIIs -1260.59 -336
DIIs -704.36 -676.67


Non-Nifty Results:

Escorts, Rossari Biotech, Macrotech Developers, Mindspace Business Parks REIT, Anup Engineering, Asian Star Co, Balkrishna Industries, Cholamandalam Financial Holdings, Greenpanel Industries, HIL, Indigo Paints, Jindal Stainless, Kesoram Industries, Monte Carlo Fashions, Privi Speciality Chemicals, Saint-Gobain Sekurit India, SKF India, Texmaco Infrastructure & Holdings, Texmaco Rail & Engineering, Vimta Labs

Tata Power Q4FY21 (Consolidated, QoQ) Revenue up 33% at Rs 10,127.39 crore Vs Rs 7,597.91 crore Net profit up 58% at Rs 392.94 crore Vs Rs 248.21 crore Ebitda down 17% at Rs 1,445.61 crore Vs Rs 1,749.59 crore Ebidta margins at 14.3% Vs 23% Recommended a dividend of Rs 1.55 per share

Jindal Steel & Power Q4FY21 (Consolidated, QoQ) Revenues up 13% at Rs 11,880.61 crore Vs Rs 10,533.51 crore Net profit down 13% at Rs 1,968.24 crore Vs Rs 2,254.66 crore Ebitda up 24% at Rs 5,287.49 crore Vs Rs 4,252.41 crore Margins at 44.5% vs 40.4%
Pidilite Q4FY21 (Consolidated, QoQ) Revenue down 3% at Rs 2,235.52 crore Vs Rs 2,299.02 crore Net profit down 31% at Rs 306.19 crore Vs Rs 441.83 crore Ebitda down 28% at Rs 460.79 crore Vs Rs 640.82 crore Ebitda Margin at 20.6% vs 27.9% Recommended a dividend of Rs 8.50 per share for FY21

Apollo Tyres Q4FY21 (Consolidated, QoQ) Revenue down 3% at Rs 5,025.6 crore Vs Rs 5,194.6 crore Net profit down 35% at Rs 287.2 crore Vs Rs 443.8 crore Ebitda down 21% at Rs 814.4 crore vs Rs 1,030 crore Ebitda Margins at 16.2% vs 19.8% Recommended a final dividend of Rs 3.50 per share for FY21

News Update:

Royal Enfield:

To temporarily halt production at its manufacturing facilities in Chennai for four days over rising Covid-19 cases. The company’s manufacturing operations across Thiruvottiyur, Oragadam & Vallam Vadagal to remain shut between May 13-16. It will undertake maintenance activity at production facilities. The company does not foresee any significant impact on its ability to cater to the demand

Tata Power:

Approved issuance of listed NCDs up to an aggregate amount of Rs 5,500 crore. The funds raised will be utilised for refinancing existing loans.

Torrent Power:

Board to consider raising up to Rs 2,000 crore by issuance of NCDs through private placement basis.

Dr. Reddy’s:

Teva and Eagle said a branded version of a cancer drug proposed by Dr. Reddy’s infringes 14 patents for Teva’s Bendeka. Teva is seeking a court order blocking sales of Dr. Reddy’s proposed drug until the patents have expired and cash compensation if Dr. Reddy’s makes or sells it before then, according to 66-page complaint filed Thursday in federal court in Wilmington, Delaware

KEC International:

Has secured new orders of Rs 1,514 crore across its various businesses. The company has secured orders of Rs 326 crore for Transmission & Distribution projects and orders of Rs 153 crore for various types of cables. The company has secured orders of Rs 1,035 crore for the construction of an elevated viaduct along with stations for a metro project and for mechanical & civil works in two cement plants.

Source: Moneycontrol, Livemint, Business Standard, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting , or e-mailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.